Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 2Papillomavirus Infections 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

pomalidomide 1plerixafor 1abemaciclib 1Papillomavirus Vaccines 1Nivolumab 1Maraviroc 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Amyloid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Acquired Immunodeficiency Syndrome × Papillomavirus Vaccines × Clear all
NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡